- Thomas Glück, MD
Cefiderocol was active against various multiresistant pathogens, including those producing ß-lactamases and carbapenemases.
- Frederick A. Masoudi, MD, MSPH, FACC, FAHA
Stem cell therapy for this indication is ineffective, but U.S. stem cell centers don't mention this.
- Richard T. Ellison III, MD
Analysis of ventilator-associated complications indicates that these two surveillance definitions identify different conditions.
- Jaime Toro, MD
Playing high school football in the 1950s did not increase the risk for cognitive disorders or depression in later life.
- Allan S. Brett, MD
A research team suggests that a 25-hydroxyvitamin D level of 12 ng/mL (30 nmol/L) might be a more appropriate cutoff.
- Alain Joffe, MD, MPH, FAAP
Only one fourth of eligible 11-year-olds received Tdap, human papillomavirus, and quadrivalent meningococcal vaccinations at the same visit.
- Atif Zaman, MD, MPH
Smoking, alcohol use, illicit drug use, poor diet, and physical inactivity accounted for at least half of excess mortality risk in hepatitis C virus–infected patients.
- Robert T. Naismith, MD
Disease-modifying therapies were most effective if started within 3 years of diagnosis in a registry study.
- Anthony S. Kim, MD
Recanalization rates were similar with both strategies.
- Patricia Kritek, MD
Angiotensin II raised blood pressure in patients with vasodilatory shock.
- Robert C. Knowlton, MD, MSPH
Researchers identify risk factors for and consequences of missing the diagnosis of out-of-hospital nonconvulsive status epilepticus.
- Seemant Chaturvedi, MD
A meta-analysis of observational studies suggests no increased risk for hemorrhage recurrence and reduced risk for ischemic stroke with vitamin K antagonists but not with antiplatelet drugs.
- Michael S. Okun, MD
If methods of preparation can be sorted out, MP could provide an alternative to levodopa in regions of the world without levodopa access.
- David A. Johnson, MD
Less than 10% of patients achieved complete remission after years of therapy, and most who did relapsed shortly after drug discontinuation.
- Jonathan Silver, MD
The sleep supplement produced higher levels of reactive aggression in a cohort of healthy young men.
- Daniel J. Pallin, MD, MPH
A retrospective comparison of care in an ED versus a specialized sickle cell clinic finds ED analgesia to be stingy.
- Joel Yager, MD
A novel medication yielded short-term moderate effects in reducing these difficult-to-treat symptoms.
- David Green, MD, PhD
Response rates were higher with decitabine, especially in higher-risk patients.
- Richard T. Ellison III, MD
In California, 74% of hospitals underreported SSIs following colon surgery, and 35% underreported SSIs following abdominal hysterectomy.
- David J. Bjorkman, MD, MSPH (HSA), SM (Epid.)
Limited data support OTSC use for rescue therapy but not primary therapy.
NEJM Open Forum
On the Horizon